1. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer;Hainsworth;J. Clin. Oncol.,1998
2. Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin;Seymour;J. Clin. Oncol.,2002
3. Eco-evolution of cancer resistance;Klement;Sci. Transl. Med.,2016
4. Repopulation of cancer cells during therapy: an important cause of treatment failure;Kim;Nat. Rev. Cancer,2005
5. Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells;Bertolini;Cancer Res.,2003